WEC
CHNA

Winslow Evans & Crocker’s Loncar China BioPharma ETF CHNA Stock Holding History

Winslow Evans & Crocker’s Portfolio CHNA Stock Details CHNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$15K Buy
+470
New +$14.4K ﹤0.01% 869

Other funds holding CHNA

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FEM
Fulcrum Equity Management Plano, Texas $136M AUM 42.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Winslow Evans & Crocker's CHNA Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Loncar China BioPharma ETF (CHNA) in Q4 2020: 470 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #869 among its holdings.

7 funds tracked by Wall St. Rank hold CHNA as of Q4 2020.

  • Winslow Evans & Crocker held 470 shares of Loncar China BioPharma ETF worth $15K as of Q4 2020.
  • Loncar China BioPharma ETF was a new Winslow Evans & Crocker position in Q4 2020.
  • Loncar China BioPharma ETF made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #869 holding.
  • 7 funds tracked by Wall St. Rank held Loncar China BioPharma ETF as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.